BCL7B antibody

Catalog No. ABIN7111913

Product Details anti-BCL7B Antibody

Target: BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BCL7B antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Purification: Immunogen affinity purified

Purity: ≥95 % as determined by SDS-PAGE

Immunogen: B-cell CLL/lymphoma 7B

Isotype: IgG

Application Details

Application Notes: WB: 1:500-1:2000, IHC: 1:20-1:200

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Expiry Date: 12 months

Target Details for BCL7B

Target: BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))

Alternative Name: BCL7B (BCL7B Products)

Synonyms: bcl7b antibody, zgc:103501 antibody, wu:fb94h01 antibody, zgc:85678 antibody, B-cell CLL/lymphoma 7B, b antibody, B-cell CLL/lymphoma 7B, a antibody, B-cell CLL/lymphoma 7B antibody, B-cell CLL/lymphoma 7b antibody, B cell CLL/lymphoma 7B antibody, BCL tumor suppressor 7B antibody, bcl7bb antibody, bcl7ba antibody, bcl7b antibody, Bcl7b antibody, BCL7B antibody

Background: Synonyms: Background:Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1(PubMed:25569233). Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation(PubMed:25569233). May play a role in lung tumor development or progression(By similarity).

Molecular Weight: 45 kDa

Gene ID: 9275

UniProt: Q9BQE9